Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2025. Further, the company has informed the Exchange regarding voting results.

Par Drugs and Chemicals Limited held its 26th AGM on September 27, 2025, in Vadodara, Gujarat, with 42 shareholders (6 promoters, 36 public) attending out of 14,498 total shareholders. All seven resolutions were passed with requisite majority: (1) adoption of audited financial statements for FY ended March 31, 2025 (99.99% in favour); (2) re-appointment of Mr. Falgun Vallabhbhai Savani as Chairman & Managing Director via retirement by rotation (93.74% in favour); (3) re-appointment of statutory auditors M/s Sarupria Somani & Associates for one year (99.85% in favour); (4) special resolution to fix remuneration of Independent Director Mr. Pravin Manjibhai Bhayani (99.85% in favour); (5) appointment of M/s DG Patel & Associates as Secretarial Auditors for a five-year term (FY 2025-26 to FY 2029-30) (99.84% in favour); (6) ratification of Cost Auditors' remuneration (99.85% in favour); and (7) special resolution to re-appoint Mrs. Bintal Bhaveshkumar Shah as Independent Director for a second term of five years ending September 27, 2030 (99.85% in favour). Remote e-voting and ballot-paper voting were both conducted, with Dip Patel of DG Patel & Associates acting as Scrutinizer. No invalid votes were recorded on any resolution.